Our analysis of the four studies identified significantly higher levels of VEGF in patients with thrombosis versus those patients without (mean difference 123.12 pg/mL, 95% CI 55.42–190.82,p = 0.0004) (Fig. 2). The gene discussed is VEGFA; the disease is deep vein thrombosis.